Analyst Price Targets — AMGN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 20, 2026 8:14 pm | — | Canaccord Genuity | $366.00 | $350.16 | TheFly | Amgen initiated with a Hold at Canaccord |
| April 10, 2026 12:50 pm | Terence Flynn | Morgan Stanley | $326.00 | $352.59 | TheFly | Amgen price target raised to $326 from $309 at Morgan Stanley |
| April 9, 2026 11:44 am | — | Guggenheim | $351.00 | $355.60 | TheFly | Amgen price target raised to $351 from $347 at Guggenheim |
| April 8, 2026 12:23 pm | — | Truist Financial | $325.00 | $349.81 | TheFly | Amgen price target raised to $325 from $319 at Truist |
| March 10, 2026 9:37 am | Akash Tewari | Jefferies | $350.00 | $373.08 | StreetInsider | Jefferies Starts Amgen (AMGN) at Hold |
| March 5, 2026 9:16 pm | David Risinger | Leerink Partners | $355.00 | $367.60 | StreetInsider | Leerink Partners Reiterates Market Perform Rating on Amgen (AMGN), lowers estimates |
| February 19, 2026 9:19 pm | — | Barclays | $185.00 | $375.50 | TheFly | Amgen initiated with an Equal Weight at Barclays |
| February 19, 2026 11:27 am | — | Wells Fargo | $375.00 | $379.73 | TheFly | Amgen price target raised to $375 from $325 at Wells Fargo |
| February 18, 2026 11:42 am | — | Piper Sandler | $432.00 | $373.36 | TheFly | Amgen price target raised to $432 from $381 at Piper Sandler |
| February 11, 2026 12:51 pm | — | Mizuho Securities | $295.00 | $364.65 | TheFly | Amgen price target raised to $295 from $280 at Mizuho |
Latest News for AMGN
On April 20, 2026, we present a DCF analysis for Amgen Inc (AMGN), a biopharmaceutical company known for its innovative therapies. The stock has shown a solid p
In the most recent trading session, Amgen (AMGN) closed at $355.3, indicating a +1.69% shift from the previous trading day.
Argo Wealth Advisory LLC acquired a new position in shares of Amgen Inc. (NASDAQ: AMGN) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 8,130 shares of the medical research company's stock, valued at approximately $2,661,000. Amgen makes up 1.6% of Argo Wealth Advisory
Farther Finance Advisors LLC increased its holdings in shares of Amgen Inc. (NASDAQ: AMGN) by 65.5% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 28,191 shares of the medical research company's stock after acquiring an additional 11,156 shares during
Assetmark Inc. grew its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 6.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 228,134 shares of the medical research company's stock after buying an additional 14,341 shares during the period.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.